Volitionrx Stock Performance
| VNRX Stock | USD 0.35 0.02 5.41% |
The entity has a beta of 2.25, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Volitionrx will likely underperform. At this point, Volitionrx has a negative expected return of -0.93%. Please make sure to validate Volitionrx's maximum drawdown and the relationship between the kurtosis and price action indicator , to decide if Volitionrx performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Volitionrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2025. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 20.7 M | |
| Total Cashflows From Investing Activities | -573.9 K |
Volitionrx | Build AI portfolio with Volitionrx Stock |
Volitionrx Relative Risk vs. Return Landscape
If you would invest 68.00 in Volitionrx on August 16, 2025 and sell it today you would lose (33.00) from holding Volitionrx or give up 48.53% of portfolio value over 90 days. Volitionrx is currently does not generate positive expected returns and assumes 4.735% risk (volatility on return distribution) over the 90 days horizon. In different words, 42% of stocks are less volatile than Volitionrx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Volitionrx Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Volitionrx's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Volitionrx, and traders can use it to determine the average amount a Volitionrx's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1966
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VNRX |
Estimated Market Risk
| 4.74 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.93 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Volitionrx is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Volitionrx by adding Volitionrx to a well-diversified portfolio.
Volitionrx Fundamentals Growth
Volitionrx Stock prices reflect investors' perceptions of the future prospects and financial health of Volitionrx, and Volitionrx fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Volitionrx Stock performance.
| Return On Equity | -7.3 | ||||
| Return On Asset | -1.35 | ||||
| Operating Margin | (15.49) % | ||||
| Current Valuation | 53.96 M | ||||
| Shares Outstanding | 119.15 M | ||||
| Price To Earning | (4.52) X | ||||
| Price To Book | 38.44 X | ||||
| Price To Sales | 33.48 X | ||||
| Revenue | 1.23 M | ||||
| EBITDA | (25.62 M) | ||||
| Cash And Equivalents | 16.42 M | ||||
| Cash Per Share | 0.28 X | ||||
| Total Debt | 5.82 M | ||||
| Debt To Equity | 1.57 % | ||||
| Book Value Per Share | (0.31) X | ||||
| Cash Flow From Operations | (25.89 M) | ||||
| Earnings Per Share | (0.24) X | ||||
| Total Asset | 9.4 M | ||||
| Retained Earnings | (229.54 M) | ||||
| Current Asset | 6.22 M | ||||
| Current Liabilities | 1.12 M | ||||
About Volitionrx Performance
Evaluating Volitionrx's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Volitionrx has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Volitionrx has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company operates Nucleosomics a technology platform for blood test. Volitionrx operates under Diagnostics Research classification in the United States and is traded on AMEX Exchange. It employs 83 people.Things to note about Volitionrx performance evaluation
Checking the ongoing alerts about Volitionrx for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Volitionrx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Volitionrx generated a negative expected return over the last 90 days | |
| Volitionrx has some characteristics of a very speculative penny stock | |
| Volitionrx has high historical volatility and very poor performance | |
| Volitionrx has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.23 M. Net Loss for the year was (27.26 M) with profit before overhead, payroll, taxes, and interest of 1.32 M. | |
| Volitionrx currently holds about 16.42 M in cash with (25.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28. | |
| Volitionrx has a poor financial position based on the latest SEC disclosures | |
| Roughly 17.0% of the company outstanding shares are owned by insiders | |
| Latest headline from news.google.com: Tempest Therapeutics Inc.s volatility index tracking explained - Long Setup Weekly Return Optimization Plans - newser.com |
- Analyzing Volitionrx's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Volitionrx's stock is overvalued or undervalued compared to its peers.
- Examining Volitionrx's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Volitionrx's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Volitionrx's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Volitionrx's stock. These opinions can provide insight into Volitionrx's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Volitionrx Stock Analysis
When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.